Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × ipatasertib × Clear all

NCT03385655 2025-08-21

Prostate Cancer Biomarker Enrichment and Treatment Selection

Phase 2 Active not recruiting

Prostatic Neoplasms